返回
Jiangsu Recbio Technology Co., Ltd.（02179.HK）價格
02179.HK 股價走勢圖
RECBIO-B (02179.HK)
Jiangsu Recbio Technology Co., Ltd.
HK$0
0%
$0
盤中： Jan 19, 15:02:30 HKT
關鍵數據
前收市價
$5.7
開盤價
--
當日範圍
-
52週區間
-
交易量
--
平均成交量
44.4K
每股盈餘 (TTM)
-1.51
股息收益率
--
市值
--
什麼是 RECBIO-B？
Jiangsu Recbio Technology Co., Ltd. engages in the research and development of vaccines. The company is headquartered in Taizhou, Jiangsu and currently employs 507 full-time employees. The company went IPO on 2022-03-31. The firm is still in the research and development stage. The firm's vaccine pipeline includes recombinant human papillomavirus (HPV) 9-valent vaccine, novel adjuvanted recombinant HPV 9-valent vaccine, recombinant HPV bivalent (Types 16/18) vaccine, recombinant HPV bivalent (Types 6/11) vaccine, novel adjuvanted recombinant HPV quadrivalent vaccine, novel adjuvanted recombinant shingles vaccine, novel adjuvanted recombinant respiratory syncytial virus vaccine, recombinant metapneumovirus vaccine, recombinant human cytomegalovirus vaccine, recombinant bicomponent COVID-19 vaccine, recombinant hepatitis B virus vaccine, and others.
